Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial

BACKGROUND: Two most important factors determining treatment success in chronic myeloid leukemia (CML) are adequate medication compliance and molecular monitoring albeit still being suboptimal. The CMyLife platform is an eHealth innovation, co-created with and for CML patients, aiming to improve the...

Descripción completa

Detalles Bibliográficos
Autores principales: Verweij, Lynn, Ector, Geneviève I. C. G., Smit, Yolba, van Vlijmen, Bas, van der Reijden, Bert A., Hermens, Rosella P. M. G., Blijlevens, Nicole M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994406/
https://www.ncbi.nlm.nih.gov/pubmed/36890512
http://dx.doi.org/10.1186/s12913-023-09153-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994406/
https://www.ncbi.nlm.nih.gov/pubmed/36890512
http://dx.doi.org/10.1186/s12913-023-09153-9

Ejemplares similares